Atlas Trials

A Multiple Dose Study to Evaluate the Effect of SHR-1222 Injection in Postmenopausal Osteoporosis Patients

Clinical trial NCT04435158 · COMPLETED

Trial details

NCT number
NCT04435158
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Osteoporosis
Start date
2020-08-25
Primary completion
2022-07-18
Enrollment
107

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.